2011, Number 3
<< Back Next >>
Med Sur 2011; 18 (3)
Enfermedad poliquística hepática asociada a enfermedad poliquística renal autosómica dominante
García GM, Sánchez-Zavala J, Mckinney NI, Corrales RB, Zavala GC, Brizuela AD, Herrera BH, Albores SJ, González CO
Language: Spanish
References: 11
Page: 132-135
PDF size: 215.78 Kb.
ABSTRACT
Autosomal dominant polycystic kidney disease (ADPKD) is the most
common inherited disorder; it is associated with mutations within
genes that encode polycystins 1 and 2. These involve chromosomes
16 and 4 respectively. This entity develops extrarenal manifestations
cystic and noncystic; ADPKD is more than a cystic disease affecting
the kidneys and the liver. Extrarenal noncystic manifestations of
ADPKD include vascular manifestations such as intracranial aneurysms.
The polycystic liver disease can exist as isolated form or in
association with ADPKD.
REFERENCES
Gabow PA. Autosomal dominant polycystic kidney disease. N Engl J Med 1993; 329: 332.
Turco A, Clementi M, Rosetti S, Tenconi R, Pignatfi P. Italian family with autosomal dominant polycystic kidney disease unliked either to the PKD1 or PKD2 gene. Am J Kidney Dis 1998; 28: 759-61.
Masyuk T, LaRusso N. Polycistic liver disease: new insights into disease pathogenesis. Hepatology 2006; 43: 906-8.
Qian Q, Li A, King B, Kamath P, Lager D, Huston J, et al. Clinical Profile of Autosomal Dominant Polycystic Liver Disease. Hepatology. 2003; 37: 164-71.
Everson GT, Taylor MRG, Doctor RB. Polycystic disease of the liver. Hepatology 2004; 40: 774-80.
Torres V, Harris P. Autosomal dominant polycystic kidney disease. Kidney Internat 2009; 76: 149-68.
Torres VE, King BF, Chapman AB. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 2007; 2: 112-20.
Bistritz L, Tamboli C, Bigam D, Bain VG. Polycystic liver disease: experience at a teaching hospital. Am J Gastroenterol 2005; 100: 2212-7.
Karhunen PJ, Tenhu M. Adult polycystic liver and kidney diseases are separate entities. Clin Genet 1996; 30: 29-37.
Zhao X, Paterson AD, Zahirieh A. Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations. Clin J Am Soc Nephrol 2008; 3: 146.
Arnold H, Harrison S. New Advances in Evaluation and Management of Patients with Polycystic Liver Disease. Am J Gastroenterol 2005; 100: 2569-82.